-
AbbVie and Boehringer settle Humira biosimilar patent dispute in US
pharmaceutical-technology
May 16, 2019
AbbVie and Boehringer Ingelheim have settled a patent dispute in the US over Cyltezo (adalimumab-adbm), a biosimilar of Humira (adalimumab).
-
Statement from FDA on Policy Advancements to Help Bring Interchangeable Biosimilars to Market
americanpharmaceuticalreview
May 15, 2019
The U.S. Food and Drug Administration (FDA) plays an important role in helping to address the high cost of medicines through the development of science-based policies that can improve competition...
-
Super-blockbuster: Trastuzumab
PharmaSources/1℃
May 14, 2019
As one of the three super-blockbusters of Roche, trastuzumab has accumulatively brought over CHF80 billion sales revenue.
-
Based on China to Go International: The Trastuzumab Biosimilar HLX02 Applied for Marketing
PharmaSources/1℃
May 14, 2019
The marketing of the drug in China will mark a milestone.
-
Celltrion Healthcare & Pfizer’s biosimilar shows positive results in Crohn’s disease study
europeanpharmaceuticalreview
May 08, 2019
Celltrion Healthcare presented the primary outcome from its pivotal randomised controlled trial of CT-P13 (biosimilar infliximab) in Crohn’s disease.
-
FDA Approves Eticovo
drugs
May 06, 2019
FDA Approves Eticovo (etanercept-ykro), a Biosimilar to Enbrel.
-
Hot Battle! Which to be the Next “Hanlikang”?
PharmaSources/Caicai
April 23, 2019
A drug has been approved for marketing on an ordinary day! It seems nothing, but in fact, it means something!
-
Sandoz resubmits BLA for biosimilar pegfilgrastim to FDA
pharmaceutical-technology
April 23, 2019
Sandoz resubmits BLA for biosimilar pegfilgrastim to FDA
-
Napp launches pegfilgrastim biosimilar in the UK
pharmatimes
April 04, 2019
Napp Pharmaceuticals has launched Pelmeg in the UK, marking the group's first launch of a product developed by Cinfa Biotech, acquired by the Mundipharma network of independent associated companies in October last year.
-
Lupin’s Pune Biotech facility receives EU GMP clearance
expressbpd
March 28, 2019
The GMP certification confirms that Lupin has a robust manufacturing facility that ensures consistent and controlled production as per EU quality standards.